Articles

Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis

Department of Laboratory Medicine, Medical University of Vienna, Vienna;Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna
Department of Laboratory Medicine, Medical University of Vienna, Vienna
Department of Laboratory Medicine, Medical University of Vienna, Vienna
Department of Laboratory Medicine, Medical University of Vienna, Vienna;Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna
Department of Pathology, Medical University of Vienna, Vienna
Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna;Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna
Department of Pathology, Medical University of Vienna, Vienna
Department of Laboratory Medicine, Medical University of Vienna, Vienna;Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna
Ludwig Boltzmann Institute of Osteology, Hanusch Hospital, Vienna
Department of Pathology, Medical University of Vienna, Vienna
Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna;Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna
Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna;Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna
Department of Laboratory Medicine, Medical University of Vienna, Vienna;Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna;Central Institute of Medical and Chemical Laboratory Diagnostics, University Hospital Innsbruck, Innsbruck, Austria
Vol. 105 No. 2 (2020): February, 2020 https://doi.org/10.3324/haematol.2019.217950